Ignite Creation Date:
2025-12-24 @ 12:51 PM
Ignite Modification Date:
2026-02-20 @ 4:47 PM
Study NCT ID:
NCT00089661
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2004-08-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20040135
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None